DexCom (DXCM) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
DexCom (DXCM) PT Raised to $130 at Morgan Stanley
August 3, 2018 7:46 AM EDTMorgan Stanley raised its price target on DexCom (NASDAQ: DXCM) to $130.00 (from $70.00) while maintaining a Equalweight rating.
... MoreDexCom (DXCM) PT Raised to $125 at Oppenheimer
August 2, 2018 9:29 AM EDTOppenheimer raised its price target on DexCom (NASDAQ: DXCM) to $125.00 (from $85.00) while maintaining an Outperform rating.
Analyst Steven Lichtman commented, "DexCom's 2Q18 sales of $243M (+41% cc) delivered a strong beat versus our/consensus $202/$206M forecasts, led by robust outperformance in both US and... More
DexCom (DXCM) PT Raised to $120 at Cowen Following 'Monster' Qtr
August 2, 2018 7:59 AM EDTCowen raised its price target on DexCom (NASDAQ: DXCM) to $120.00 (from $110.00) while maintaining a Outperform rating following its "huge" beat and raise.
Analyst Doug Schenkel commented, "DXCM posted a huge beat and raise. Deals with payers to expand access / simplify distribution could temper... More
